Peck Ronald 4/A
4/A · ARVINAS, INC. · Filed Aug 16, 2022
Insider Transaction Report
Form 4/AAmended
ARVINAS, INC.ARVN
Peck Ronald
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-08-12−4,010→ 4,010 total→ Common Stock (4,010 underlying) - Sale
Common Stock
2022-08-12$54.84/sh−1,258$68,994→ 8,154 total - Exercise/Conversion
Common Stock
2022-08-12+4,010→ 9,412 total
Footnotes (4)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
- [F3]This amendment is being filed to correct the sales price reported on the reporting person's Form 4 filed on August 16, 2022.
- [F4]On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.